Celanese Corp CE
This Annual Report on Form 10-K includes industry data obtained from industry publications and surveys, as well as our own internal company surveys. Third-party industry publications, surveys and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable.
We are a global chemical and specialty materials company. We are a global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.54B | $10.27B | $10.93B | $9.67B | $8.54B | $5.66B | $6.30B | $7.16B | $6.14B | $5.39B |
| Cost of revenue | $7.59B | $7.93B | $8.34B | $7.29B | $5.86B | $4.36B | $4.69B | $5.18B | $4.63B | $3.98B |
| Gross profit | $1.95B | $2.34B | $2.58B | $2.38B | $2.68B | $1.29B | $1.61B | $1.97B | $1.51B | $1.41B |
| R&D | $125.0M | $130.0M | $146.0M | $112.0M | $86.0M | $74.0M | $67.0M | $72.0M | $73.0M | $78.0M |
| SG&A | $899.0M | $1.03B | $1.08B | $824.0M | $633.0M | $482.0M | $483.0M | $546.0M | $496.0M | $378.0M |
| Operating income | -$786.0M | -$720.0M | $1.67B | $1.38B | $1.95B | $664.0M | $834.0M | $1.33B | $857.0M | $934.0M |
| Interest expense | $701.0M | $676.0M | $720.0M | $405.0M | $91.0M | $109.0M | $115.0M | $125.0M | $122.0M | $120.0M |
| Pre-tax income | -$1.22B | -$1.02B | $1.16B | $1.42B | $2.25B | $2.25B | $988.0M | $1.51B | $1.07B | $1.03B |
| Income tax | $90.0M | $507.0M | $795.0M | $489.0M | $330.0M | $247.0M | $124.0M | $292.0M | $213.0M | $122.0M |
| Net income | -$1.17B | -$1.54B | $1.94B | $1.89B | $1.89B | $1.99B | $852.0M | $1.21B | $843.0M | $900.0M |
| EPS, basic | -10.64 | -14.11 | 17.85 | 17.48 | 16.99 | 16.85 | 6.88 | 8.99 | 6.11 | 6.21 |
| EPS, diluted | -10.64 | -14.11 | 17.76 | 17.34 | 16.86 | 16.75 | 6.84 | 8.91 | 6.09 | 6.18 |
| Shares, diluted (wtd. avg.) | $109.5M | $109.3M | $109.4M | $109.2M | $112.1M | $118.5M | $124.7M | $135.4M | $138.3M | $145.7M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $1.26B | $962.0M | $1.80B | $1.51B | $536.0M | $955.0M | $463.0M | $439.0M | $576.0M | $638.0M |
| Short-term investments | — | — | — | — | $10.0M | $533.0M | $40.0M | $31.0M | $32.0M | $30.0M |
| Receivables | $922.0M | $1.12B | $1.24B | $1.38B | $1.16B | $792.0M | $850.0M | $1.02B | $986.0M | $801.0M |
| Inventory | $2.22B | $2.28B | $2.36B | $2.81B | $1.52B | $978.0M | $1.04B | $1.05B | $900.0M | $720.0M |
| Total current assets | $5.69B | $5.13B | $6.22B | $6.61B | $3.81B | $3.76B | $2.77B | $2.87B | $2.79B | $2.47B |
| Property, plant and equipment | $5.08B | $5.27B | $5.58B | $5.58B | $4.19B | $3.94B | $3.71B | $3.72B | $3.76B | $3.58B |
| Goodwill | $4.17B | $5.39B | $6.98B | $7.14B | $1.41B | $1.17B | $1.07B | $1.06B | $1.00B | $796.0M |
| Other intangibles | $3.18B | $3.64B | $3.98B | $4.11B | $735.0M | $319.0M | $312.0M | $310.0M | $301.0M | $194.0M |
| Total assets | $21.70B | $22.84B | $26.60B | $26.27B | $11.97B | $10.91B | $9.48B | $9.31B | $9.54B | $8.36B |
| Accounts payable | $1.28B | $1.23B | $1.51B | $1.52B | $1.16B | $797.0M | $780.0M | $819.0M | $807.0M | $625.0M |
| Short-term debt | $1.20B | $1.50B | $1.38B | $1.31B | $791.0M | $496.0M | $496.0M | $561.0M | $326.0M | $118.0M |
| Total current liabilities | $3.68B | $3.89B | $4.07B | $4.07B | $2.50B | $1.97B | $1.75B | $1.78B | $1.56B | $1.08B |
| Long-term debt | $12.61B | $12.53B | $13.40B | $13.95B | $3.72B | $3.67B | $3.46B | $2.97B | $3.31B | $2.89B |
| Retained earnings | $9.88B | $11.05B | $12.93B | $11.27B | $9.68B | $8.09B | $6.40B | $5.85B | $4.92B | $4.32B |
| Total equity | $4.05B | $5.13B | $7.07B | $5.64B | $4.19B | $3.53B | $2.51B | $2.98B | $2.89B | $2.59B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.15B | $966.0M | $1.90B | $1.82B | $1.76B | $1.34B | $1.45B | $1.56B | $803.0M | $893.0M |
| Depreciation and amortisation | $760.0M | $801.0M | $706.0M | $462.0M | $371.0M | $350.0M | $352.0M | $343.0M | $305.0M | $290.0M |
| Stock-based compensation | $24.0M | $32.0M | $40.0M | $60.0M | $95.0M | $28.0M | $48.0M | $71.0M | $47.0M | $31.0M |
| Capital expenditure | $343.0M | $435.0M | $568.0M | $543.0M | $467.0M | $364.0M | $370.0M | $337.0M | $267.0M | $246.0M |
| Investing cash flow | -$349.0M | -$470.0M | -$134.0M | -$11.14B | -$1.12B | $592.0M | -$493.0M | -$507.0M | -$549.0M | -$439.0M |
| Financing cash flow | -$513.0M | -$1.31B | -$1.46B | $10.29B | -$1.04B | -$1.47B | -$935.0M | -$1.17B | -$351.0M | -$759.0M |
| Dividends paid | $13.0M | $307.0M | $305.0M | $297.0M | $304.0M | $293.0M | $300.0M | $280.0M | $241.0M | $201.0M |
| Buybacks | — | $0 | $0 | $17.0M | $1.00B | $650.0M | $996.0M | $805.0M | $500.0M | $500.0M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001306830-26-000031.
Others in SIC 2820
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| CTA-PB | EIDP, Inc. | — | — | — |